DOCSLIB.ORG

CSE Marijuana List Showing 178 of 712 Listings

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
CSE Marijuana List Showing 178 of 712 Listings CSE Marijuana List Showing 178 of 712 listings Listing Company Sector Company Description Date 1933 Industries is a Nevada-based, growth-orientated company, focusing on the cultivation and manufacturing of cannabis consumer branded goods in a wide range of product formats. Operating through two subsidiaries, the Company controls all aspects of 1933 Industries US the value chain with cultivation, extraction, processing, 16-Jun-17 Inc. (CSE:TGIF) Cannabis and manufacturing assets supporting its diversified portfolio of cannabis brands and licensing partners. The Company owns 91% of Alternative Medicine Association, LC (AMA), and 100% of Infused MFG LLC. www.1933industries.com ... 4Front Ventures Corp. is a vertically-integrated cannabis company with cultivation, production and retail facilities spread across several states in the US. Share Classes 4Front has two classes of shares: subordinate voting shares (“SVS”) and multiple voting shares (“MVS”). SVS are publicly traded on the CSE and are entitled to one vote. MVS are not publicly traded, 4Front Ventures US can convert to SVS at a ratio of 1 MVS to 1 SVS, and 14-Mar-18 Corp. (CSE:FFNT) Cannabis are entitled to 800 votes per MVS. There are 592,627,966 SVS outstanding and 1,276,208 MVS convertible to 1,276,208 outstanding for a total outstanding SVS of 593,904,174 on an as-converted basis. Please see Section 10 - Description of Securities of 4Front's Form 2A Listing Statement for a further description of the SVS and MVS. Each Warrant entitles the holder thereof, upon exercise 4Front Ventures at any time after the Issue Date and prior to the Expiry US Corp. Wts Time, to acquire one (1) Warrant Share upon payment 23-Nov-20 Cannabis (CSE:FFNT.WT) of the Exercise Price of $0.90. See the Warrant Indenture for full details. 1 Headquartered in New York City, Acreage is a vertically integrated, multi-state operator of cannabis ‎licenses and assets in the U.S. Acreage is dedicated to building and scaling operations to create a ‎seamless, consumer- focused branded cannabis experience. Acreage debuted its national retail store ‎brand, The Botanist in 2018 and its award-winning consumer brands, The Botanist and Live Resin Project ‎in 2019.‎ Class E subordinate voting share (each, a “Fixed Share”) of the Company was created pursuant to the Amended Plan of Arrangement. Each Fixed Share entitles the holder to one vote per share at shareholder meetings of the Company. Each Fixed Share is subject to an option (the “Canopy Option”) in favour of Canopy Growth Corporation (“Canopy Growth”) pursuant to which Canopy Growth may, upon satisfaction or waiver of the conditions set out in the Amended Arrangement Agreement, acquire the Fixed Shares (the Acreage Holdings, US “Acquisition”). The Canopy Option is required to be Inc. Fixed S.V. 15-Nov-18 Cannabis exercised upon the occurrence of changes in U.S. (CSE:ACRG.A.U) federal law to permit the general cultivation, distribution, and possession of marijuana and subject to the satisfaction or waiver of certain conditions to closing as set out in the Amended Arrangement Agreement, the Acquisition will be completed. Investor Note: In addition to the 71,343,094 Fixed Shares and 30,626,805 Floating Shares that are listed and trading, there are 17,017,664 Fixed Shares and 7,242,885 Floating Shares, respectively, reserved for issuance pursuant to redemption and conversion rights attached to other share classes of Acreage Holdings, Inc., as well as certain outstanding securities of Acreage Holdings WC, Inc. and High Street Capital Partners, LLC, which are subsidiaries of Acreage Holdings, Inc. The total number of Fixed Shares and Floating Shares, as converted, is 88,360,758 and 37,869,690, respectively, excluding options, warrants, RSUs and convertible debt. 2 Headquartered in New York City, Acreage is a vertically integrated, multi-state operator of cannabis ‎licenses and assets in the U.S. Acreage is dedicated to building and scaling operations to create a ‎seamless, consumer- focused branded cannabis experience. A Class D subordinate voting share (each, a “Floating Share”) of the Company was created pursuant to the Amended Plan of Arrangement. Each Floating Share entitles the holder thereof to one vote per share at shareholder meetings of the Company. Each Fixed Share is subject to an option in favor of Canopy Growth (the “Floating Call Option”) to acquire all of the issued and outstanding Floating Shares. If exercised in accordance with the terms of the Amended Plan of Acreage Holdings, Arrangement, Canopy Growth’s acquisition of the US Inc. Floating S.V. Floating Shares will take place concurrently with, and 22-Sep-20 Cannabis (CSE:ACRG.B.U) subject to satisfaction or waiver of the same conditions as, the Acquisition. Investor Note: In addition to the 71,343,094 Fixed Shares and 30,626,805 Floating Shares that are listed and trading, there are 17,017,664 Fixed Shares and 7,242,885 Floating Shares, respectively, reserved for issuance pursuant to redemption and conversion rights attached to other share classes of Acreage Holdings, Inc., as well as certain outstanding securities of Acreage Holdings WC, Inc. and High Street Capital Partners, LLC, which are subsidiaries of Acreage Holdings, Inc. The total number of Fixed Shares and Floating Shares, as converted, is 88,360,758 and 37,869,690, respectively, excluding options, warrants, RSUs and convertible debt. Founded in 2014, Adastra Holdings Ltd. built a successful reputation as a household name in cannabis concentrates among consumers and retailers alike. Adastra Labs Inc. was founded in 2018 and is an agricultural-scale cannabis extraction, distillation, and product manufacturer, located in Langley, BC. Operating out of its 13,500 sq. ft. Health Canada Licensed Standard Processing facility, now named Adastra Holdings Ltd., produces and distributes Adastra Holdings cannabis-derived products designed for medical Cannabis 06-Jan-20 Ltd. (CSE:XTRX) cannabis and forward-looking therapeutic use. Recently, the Company announced its entry into psychedelics by applying for a Controlled Substances Dealer's License, which is under review by Health Canada. As a leading supplier, Adastra Holdings Ltd. currently distributes its product line to 1400+ adult-use retailers and a web-based medical platform, CannMart Inc., seeking to provide consistent, quality concentrate products and alternative treatment options across the country to patients. 3 AgraFlora Organics International Inc. has an experienced management team with a growth strategy to develop a diversified portfolio of projects that can be Agra Ventures Ltd taken into production. The Company’s main objective is Cannabis 19-Jun-14 (CSE:AGRA) to add shareholder value through cost efficient acquisitions, joint ventures, and effective marketing while maintaining a lower risk profile through project diversification and sound financial management. Aion Therapeutic Inc. is an early-stage cannabinoid extraction company based in Oliver, BC. Aion has applied for a standard processing license under the Cannabis Act for its 10,410 ft2 facility and that Aion Therapeutic Cannabis application is currently in the review stage. The 21-Feb-19 Inc. (CSE:AION) Company will offer contract tolling extraction, sale of bulk oil and development of both proprietary Aion Cannabis branded and white labelled products once licensed to do so. Alliance Growers Corp. (ACG:CSE) is a Diversified Global Medical Cannabis Company driven by the Company’s ‘Four Pillars’ Organization Plan – Cannabis Biotech Complex, Strategic ACMPR Investments, CBD Oil Supply and Distribution, and Research and Technology. Alliance Growers and Pharmagreen Biotech Inc. are jointly developing a 63,000-square foot Alliance Growers facility, the first of its kind in Western Canada to house Cannabis 22-Jun-15 Corp. (CSE:ACG) a DNA Botany lab, extraction facility and Tissue Culture Plantlet Production facility to service the Cannabis market and agriculture market in general. The main facility is the Cannabis Biotech Centre which will grow Cannabis plantlets utilizing the proprietary “Chibafreen Invitro Plant Production System” for tissue culture propagation, allowing more tissue cultured plantlets to be produced in less space and less time. 4 Alternate Health (CSE: AHG, OTCQB: AHGIF) an international leader in the hemp-derived CBD industry, including extraction, product development and distribution. Alternate Health’s industry-leading software systems provide the platform for the company’s diverse operations, including blockchain tax collection systems, hemp-derived CBD product distribution, extract manufacturing and patient management systems for specialty clinics across North America. T​​hrough Alternate Health’s subsidiary, Blaine Alternate Health US Labs, the Company is a leader in cGMP medical product 19-Jan-17 Corp. (CSE:AHG) Cannabis manufacturing and distribution, with over 50 product SKUs available from major retailers, including Walmart, Amazon, CVS and Walgreens. Alternate Health’s corporate office is located in Toronto, Canada, with additional offices in Venice, California, and San Antonio, Texas. The Company is well positioned to reinvest internal operating cash flow in its platform and product development over the long term, creating an attractive investment profile for its shareholders. For more information about Alternate Health Corp., visit www.alternatehealth.com. AMP is licensed to import European Union - Good Manufacturing Practice (EU-GMP) medical cannabis from Europe and elsewhere into Germany. AMP AMP Alternative sources,
Load more

Recommended publications
  • SUU Alm.Del Bilag 444: Itamar Grotto
    Sundheds- og Ældreudvalget 2017-18 SUU Alm.del Bilag 444 Offentligt MINISTRY OF HEALTH Medical Grade Cannabis - The Israeli Roadmap to Medicalization Prof. Itamar Grotto Associate Director General, Israeli Ministry of Health Medical Grade Cannabis - MINISTRY The Israeli Roadmap to Medicalization OF HEALTH Medical use of Cannabis in ancient times • 5000 years ago in Egyptian tombs • 2700 years ago in India • 2000 years ago in China for the treatment of pain Medical Grade Cannabis - MINISTRY The Israeli Roadmap to Medicalization OF HEALTH International - Single Convention on Narcotic Drugs 1961 The Cannabis plant is subject to additional measures of control Israel - The Dangerous Drug Ordinance [New Version] - 1973 The Cannabis plant and its products are defined as narcotic substances They are not registered as medicinal products Medical Grade Cannabis - MINISTRY The Israeli Roadmap to Medicalization OF HEALTH The Government of Israel Resolutions Government Resolution 3609 (7.8.2011) • Establishes the obligation of the Ministry of Health to serve as “Government Agency” for Cannabis • The multi-ministerial Stirring Committee • The Israeli Medical Cannabis Agency (IMCA) is established Government Resolution 1050 (15.12.2013) • Improving efficiency of prescription, indication inspection, appointing of Physicians and accessibility to service. • Search for feasibility of export • Regulating research. Medical Grade Cannabis - MINISTRY The Israeli Roadmap to Medicalization OF HEALTH Government Resolution 1587 (26.6.2016) - Cannabis for medical purpose and research The “Medicalization” of Cannabis Medical Grade Cannabis - MINISTRY The Israeli Roadmap to Medicalization OF HEALTH The Vision of The Israeli Medical Cannabis Agency (IMCA) To support the use of Cannabis for medical purposes exclusively, while preventing misuse and keeping public safety.
    [Show full text]
  • Israeli Cannabis Company 'Together' Announced an Agreement with a Canadian Company to Sell 50 Tons of Cannabis Inflorescences Or 5 Tons of Cannabis Oil
    Israeli cannabis company 'Together' announced an agreement with a Canadian company to sell 50 tons of cannabis inflorescences or 5 tons of cannabis oil The company estimates the potential annual revenue from the deal at hundreds of millions of shekels. "This agreement joins other existing sales agreements in Canada and German totaling 30 tons. These agreements ensure the creation of revenue and cash flow that are not dependent on export approval from the State of Israel, and which will derive from the sale of medical cannabis and its products from areas that we will set up in countries outside of Israel that have the relevant export agreements", said Globus Pharma founding partner Nissim Bracha Israel, Ashkelon, April 11 2018 – 'Together' (TASE: TGTR) announced that its activity company 'Globus Pharma', which specializes in the medical cannabis sector and operates as a subsidiary of 'Together', has signed a Memorandum of Understanding (MoU) to sell medical cannabis or oil to a Canadian company with a license to grow, produce and import medical cannabis to Canada. Under the terms of the agreement, the Canadian company will buy from Globus 50 tons of dried inflorescences of cannabis each year or five tons of medical cannabis oil (the equivalent amount to 50 tons of inflorescences) as part of the terms of the law in Canada and in Israel. In addition, the two companies will collaborate in the field of R&D and promoting technologies in the medical cannabis sector. As of the date of signing the agreement, the parties estimate that sales revenue will amount to between US$3.17 and US$4.7 per gram of inflorescence.
    [Show full text]
  • Roots Sustainable Agricultural Technologies Ltd Arbn 619 754 540 Notice of Annual General Meeting
    ROOTS SUSTAINABLE AGRICULTURAL TECHNOLOGIES LTD ARBN 619 754 540 NOTICE OF ANNUAL GENERAL MEETING Notice is given that the Meeting will be held at: TIME: 2:30 pm (WST) DATE: Thursday, 16 September 2021 PLACE: Suite 2, Level 1 1 Altona Street WEST PERTH WA 6005 The business of the Meeting affects your shareholding and your vote is important. This Notice of Meeting should be read in its entirety. If Shareholders are in doubt as to how they should vote, they should seek advice from their professional advisers prior to voting. The Directors have determined pursuant to Regulation 7.11.37 of the Corporations Regulations 2001 (Cth) and to section 182 of the Companies Law and the regulations promulgated thereunder, that the persons eligible to vote at the Meeting are those who are registered Shareholders at 5:00pm (WST) on 14 September 2021. BUSINESS OF THE MEETING AGENDA 1. FINANCIAL STATEMENT AND REPORTS Review and discussion of the audited annual financial report of the Company for the financial year ended 31 December 2020 together with the declaration of the directors, the director’s report and the auditor’s report. 2. RESOLUTION 1 – APPOINTMENT OF AUDITORS To consider and, if thought fit, to pass, with or without amendment, the following resolution: “RESOLVED, that BDO – Ziv Haft be, and hereby is, appointed as the independent auditors of the Company for the year 2021 and for an additional period until the next annual general meeting.” The affirmative vote of at least a majority of the voting power represented at the Meeting, in person or by proxy and voting thereon, is required to adopt this Resolution.
    [Show full text]
  • Dispensary Selection Information
    ______________________________________________________________________________________ State of Vermont Department of Public Safety Marijuana Registry [phone] 802-241-5115 45 State Drive [fax] 802-241-5230 Waterbury, Vermont 05671-1300 [email] [email protected] www.medicalmarijuana.vermont.gov Dispensary Selection Information IMPORTANT INFORMATION CONTAINED BELOW WHEN COMPLETING THE FORMS TO REGISTER AS A PATIENT WITH THE VERMONT MARIJUANA REGISTRY (VMR). Materials provided by each dispensary are attached to assist patient applicants designating a dispensary. Registered patients may purchase marijuana, marijuana infused products, seeds, and clones from a registered dispensary. Registered patients who designate a dispensary may purchase marijuana products and cultivate marijuana in a single secure indoor facility. Registered patients who elect to cultivate marijuana in a single secure indoor facility must provide the address and location to the VMR on his or her application. Any updates to the address and/or location of the single secure indoor facility must be submitted in writing via email or mail to the contact information below. Registered patients may only purchase marijuana, marijuana infused products, seeds, and clones from one dispensary and must designate the dispensary of his or her choice on their application. Registered patients may only change dispensaries every 30 days. After 30 days, a registered patient may change his or her designated dispensary by submitting a completed Cardholder Information Notification form and a $25 processing fee. The VMR will issue the registered patient a new registry identification card with a new registry identification number. ALL registered patients and caregivers MUST schedule appointments prior to going to their designated dispensary to obtain marijuana, this includes seed and clones.
    [Show full text]
  • Big-Catalogue-English-2020.Pdf
    PAS CH SIO UT N D ® CATALOGUE English SEED COMPANY Feminized, autoflower and regular cannabis seeds AMSTERDAM, ESTABLISHED 1987 for recreational and medical use. Amsterdam - Maastricht YOUR PASSION OUR PASSION DUTCH PASSION 02 Contents Welcome to Dutch Passion Welcome to Dutch Passion 02 Dutch Passion was the second Cannabis Seed Company in the world, established in Amsterdam in 1987. It is our mission to supply Bestsellers 2019 02 the recreational and medical home grower with the highest quality cannabis products available in all countries where this is legally Regular, Feminized and Autoflower 03 allowed. Cannabinoids 03 Medical use of cannabis 03 After many years of dedication Dutch Passion remains a leading supplier of the world’s best cannabis genetics. Our experienced Super Sativa Seed Club 04 team do their utmost to maintain the quality of our existing varieties and constantly search for new ones from an extensive network Special Cannabinoids / THC-Victory 05 of worldwide sources. We supply thousands of retailers and seed distributors around the world. Dutch Outdoor 06 High Altitude 09 CBD Rich 10 Dutch Passion have never been afraid to upset conventional thinking; we invented feminized seeds in the 1990’s and more recently Latin America 13 have pioneered the introduction of 10-week Autoflower seeds which have helped make life even easier for the self-sufficient Classics 14 cannabis grower. CBD-rich medical cannabis genetics is a new area that we are proud to be leading. Skunk Family 19 Orange Family 21 The foundation of our success is the genetic control we have over our strains and the constant influx of new genetics that we obtain Blue Family 24 worldwide.
    [Show full text]
  • Marijuana Myths and Facts: the Truth Behind 10 Popular Misperceptions
    MARIJUANA myths & FACTS The Truth Behind 10 Popular Misperceptions OFFICE OF NATIONAL DRUG CONTROL POLICY MARIJUANA myths & FACTS The Truth Behind 10 Popular Misperceptions OFFICE OF NATIONAL DRUG CONTROL POLICY TABLE OF CONTENTS Introduction.............................................................................. 1 Myth #1: Marijuana is harmless .......................................... 3 Myth #2: Marijuana is not addictive ................................... 7 Myth #3: Marijuana is not as harmful to your health as tobacco............................................................. 9 Myth #4: Marijuana makes you mellow............................. 10 Myth #5: Marijuana is used to treat cancer and other diseases...................................................... 11 Myth #6: Marijuana is not as popular as MDMA (Ecstasy) or other drugs among teens today...................... 13 Myth #7: If I buy marijuana, I’m not hurting anyone else......................................................... 14 Myth #8: My kids won’t be exposed to marijuana ............. 17 Myth #9: There’s not much parents can do to stop their kids from experimenting with marijuana ........... 19 Myth #10: The government sends otherwise innocent people to prison for casual marijuana use......... 21 Conclusion .............................................................................. 23 Glossary.................................................................................. 25 References ..............................................................................
    [Show full text]
  • Big Marijuana Claims Vs. the Science
    Big Marijuana Claims Vs. The Science Big Marijuana Claims Scientific Facts Legalization is about one thing: making a small number of business people rich. If it were about ending the War on Drugs, recent law changes would be limited to decriminalization. Rather, a host of business interests are getting involved with the legal marijuana trade in Colorado and elsewhere. Legalization is about getting rid of They have set up private equity the “War on Drugs” firms and fundraising organizations to attract investors and promote items such as marijuana food items, oils, and other products.We also know these industries target the poor and disenfranchised[i] – and we can expect the marijuana industry to do the same in order to increase profits. Science has proven – and all major scientific and medical organizations agree – that marijuana is both addictive and harmful to the human brain, Marijuana is not addictive. especially when used as an adolescent. One in every six 16 year-olds (and one in every eleven adults) who try marijuana will become addicted to it.[ii] To your brain, addiction is addiction. Different addictions have different symptoms, but whether its food, sex, marijuana, or heroin – your brain knows it wants more of that feeling of pleasure. Marijuana MIGHT be Just as with alcohol and tobacco, psychologically addictive, but its most chronic marijuana users who addiction doesn’t produce physical attempt to stop “cold turkey” will symptoms. experience an array of withdrawal symptoms such as irritability, restlessness, anxiety, depression, insomnia, and/or cravings.[iii] This signals that marijuana can be addictive. Science has shown that 1 in 6 kids who ever try marijuana, according to the National Institutes of Health, will become addicted to the drug.
    [Show full text]
  • Israel Takes the Next Steps Towards Legalizing Recreational Cannabis
    Article Cannabis Law July 2020 Israel Takes the Next Steps Towards Legalizing Recreational Cannabis By Andrew J. Wilder and Jonathan Mahoney Israel is considered one of the global leaders in medical cannabis research and innovation. In 1964, Professor Raphael Mechoulam of the Hebrew University of Jerusalem was the first person to isolate and identify THC, the psychoactive chemical component in cannabis that causes a high. While limited use of cannabis for medicinal purposes has been permitted in Israel since the early 1990s, it took 53 years from Professor Mechoulam’s breakthrough before the Public Security Ministry partially decriminalized cannabis in 2017, setting fines and treatment for initial offenders instead of criminal procedures. Earlier this year, after much bureaucratic delay, the export of medical cannabis was finally approved and is estimated to generate hundreds of millions of dollars in revenue annually. Now, three years since its decriminalization, Israel is on the verge of legalizing cannabis for recreational use. On June 9th, 2020, just one week after the State of Israel police minister declared that enforcement of the existing laws related to cannabis possession and use would be relaxed, two of Israel’s largest political parties issued a joint statement, agreeing to move forward with cannabis law reform. In the joint statement provided by Likud Prime Minister Benjamin Netanyahu and Blue and White’s Defense Minister Benny Gantz, they advised that reform to existing legislation was required with the aim to “resolve the issue of decriminalization and legalization” of cannabis in Israel. In addition to legalizing recreational cannabis, the proposed reforms will also make it easier for patients to gain access to treatment and for producers to become licensed to grow and sell medical cannabis.
    [Show full text]
  • FORM 5 QUARTERLY LISTING STATEMENT Name of Listed Issuer
    FORM 5 QUARTERLY LISTING STATEMENT Name of Listed Issuer: MPX International Corporation (“MPXI” or the “Issuer”). Trading Symbol: MPXI This Quarterly Listing Statement must be posted on or before the day on which the Issuer’s unaudited condensed interim financial statements are to be filed under the Securities Act, or, if no interim statements are required to be filed for the quarter, within 60 days of the end of the Issuer’s first, second and third fiscal quarters. This statement is not intended to replace the Issuer’s obligation to separately report material information forthwith upon the information becoming known to management or to post the forms required by the Exchange Policies. If material information became known and was reported during the preceding quarter to which this statement relates, management is encouraged to also make reference in this statement to the material information, the news release date and the posting date on the Exchange website. Currency Unless otherwise stated, all dollar amounts are expressed in Canadian dollars. General Instructions (a) Prepare this Quarterly Listing Statement using the format set out below. The sequence of questions must not be altered nor should questions be omitted or left unanswered. The answers to the following items must be in narrative form. When the answer to any item is negative or not applicable to the Issuer, state it in a sentence. The title to each item must precede the answer. (b) The term “Issuer” includes the Listed Issuer and any of its subsidiaries. (c) Terms used and not defined in this form are defined or interpreted in Policy 1 – Interpretation and General Provisions.
    [Show full text]
  • Crack Heads and Roots Daughters: the Therapeutic Use of Cannabis in Jamaica
    Crack Heads and Roots Daughters: The Therapeutic Use of Cannabis in Jamaica Melan ie Dreher SUMMARY. An ethnographic study of women and drug use in innel city neighborhoods in Kingston, Jamaica, revealed that cannabis is com· monly used in conjunction with crack cocaine to minimize the undesir· able effects of crack pipe smoking, specificall y paranoia and weight loss According to 33 CUITent or former crack using women, who were followee for a period of nine months, cannabis cigarettes ("spliffs") constitute th' cheapest, most effective and readily available therapy for discontinuin! crack consumption. The findings of this research suggest the need te reframe "multiple drug use" within the cultural meanings that attene cannabis in Jamaica as a medicine and a sacrament. {Article copies avaif. able for a fee from The Haworrh Documenr Delivery Service: i-800-HAWORTH £·mail address: <[email protected]> Website: <http:// www HaworthPress.com> © 2002 by The Ha worth Press, In c. All rights reserved. / KEYWORDS. Cannabis, ganja, culture, crack, cocaine, Jamaica, women self-treatment, Rastafarians, multiple drug use There are only two illicit substances that are widely used in Jamaica, mario juana (or "ganja," as it is called locally) and crack cocaine. This paper de­ scribes the use of cannabis as a cheap, available therapy for the treatment 01 Melanie Dreher, PhD, FAAN, is Dean and Professor, University ofIawa College 0 1 Nursing, 10lD Nurs ing Building, 50 Newton Road, Iowa City, [A 52242-1121 (E-mail: [email protected]). [Hliworth co-indexing en try notel: "Crack Heads and Roots Daughters: The Therapeutic Use of Cannabi: in Jam aica." Dreher.
    [Show full text]
  • SR-112 Science of Hemp: Production and Pest Management
    University of Kentucky College of Agriculture, Food and Environment Agricultural Experiment Station SR-112 Science of Hemp: Production and Pest Management Science of Hemp: Production and Pest Management October 10 –11, 2019 Agricultural Kentucky Tobacco Research and Development Center | Veterinary Diagnostic Laboratory | Division of Regulatory Services | Research and Education Center Experiment Station Robinson Forest | Robinson Center for Appalachian Resource Sustainability | University of Kentucky Superfund Research Center | Equine Programs emp (Cannabis sativa with <0.3% THC content) is grown for fiber, grain, and cannabinoid extraction in Asia, Europe, and the Americas. Until recently, HCannabis sativa has been classified as a Schedule 1 controlled substance in the US. The Agricultural Act of 2014 (Farm Bill) allowed for reintroduction of industrial hemp under a pilot research program. Acreage increases and addition of state legislation resulted in over 78,000 acres of hemp grown in 23 states by the end of 2018. Hemp became a legal commodity under the 2018 Farm Bill, and by the end of 2019, over 500,000 licensed acres were documented across 45 states. Canada re-introduced the crop in 1998, and in 2018, almost 78,000 acres of hemp were licensed and planted. With this increase in acreage and the lack of modern scientific data, university and government agricultural specialists began to work on various components of production and a range of realized challenges. This new information, however, had either not been shared or was not readily accessible to the scientific community, especially early results and nonpublished data. The first annual meeting of the Science of Hemp: Production and Pest Management was held on October 10-11, 2019 at the University of Kentucky in Lexington, KY.
    [Show full text]
  • A Multifaceted Approach to Address Variation in Cannabis Sativa
    University of Northern Colorado Scholarship & Creative Works @ Digital UNC Dissertations Student Research 5-2019 A Multifaceted Approach to Address Variation in Cannabis Sativa Anna Louise Schwabe Follow this and additional works at: https://digscholarship.unco.edu/dissertations Recommended Citation Schwabe, Anna Louise, "A Multifaceted Approach to Address Variation in Cannabis Sativa" (2019). Dissertations. 554. https://digscholarship.unco.edu/dissertations/554 This Text is brought to you for free and open access by the Student Research at Scholarship & Creative Works @ Digital UNC. It has been accepted for inclusion in Dissertations by an authorized administrator of Scholarship & Creative Works @ Digital UNC. For more information, please contact [email protected]. © 2019 ANNA LOUISE SCHWABE ALL RIGHTS RESERVED UNIVERSITY OF NORTHERN COLORADO Greeley, Colorado The Graduate School A MULTIFACETED APPROACH TO ADDRESS VARIATION IN CANNABIS SATIVA A Dissertation Submitted in Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy Anna Louise Schwabe College of Natural and Health Sciences School of Biological Sciences Biological Education May 2019 This Dissertation by: Anna Louise Schwabe Entitled: A Multifaceted Approach to Address Variation in Cannabis sativa has been approved as meeting the requirement for the Degree of Doctor of Philosophy in College of Natural and Health Sciences in School of Biological Sciences, Program of Biological Education. Accepted by the Doctoral Committee ____________________________________________________
    [Show full text]